GST probe arm finds P&G India guilty of profiteering Rs 250 cr; firm says committed to pass benefits to consumers
As per GST anti-profiteering rules, companies have to pass on the benefit of reduction of taxes to consumers by way of commensurate cut in product prices.
DGAP investigated the books of accounts of P&G India pre and post 15 November, 2017
After studying the documents, the DGAP gives its report to the NAA for further action
NAA will pass a final order on the quantum of profiteering after hearing company's views
New Delhi: The GST profiteering investigation arm has found leading FMCG firm P&G India guilty of not passing on the Goods and Services Tax (GST) rate cut benefits to the tune of about Rs 250 crore by commensurate reduction in prices.
Based on a complaint filed before the standing committee, the Directorate General of Anti Profiteering (DGAP) investigated the books of accounts of P&G India pre and post 15 November, 2017, and concluded that the consumer goods manufacturer has not lowered prices of certain of its products despite cut in GST rate to 18 percent from 28 percent.
"The DGAP report has concluded profiteering worth Rs 250 crore by P&G. The National Anti Profiteering Authority (NAA) will pass a final order on the quantum of profiteering after hearing the company's views," an official said.
P&G's India is the manufacturer of washing powder brands Ariel and Tide; shampoo brands Heads & Shoulders and Pantene; cosmetics brand Olay, and shaving and dental hygiene brands Gillette and Oral-B. It also manufactures products under the brand name Ambi Pur, Pampers, Vicks and sanitary napkin Whisper.
When contacted, a P&G spokesperson said "As a responsible corporate, P&G has always been committed to passing the net benefit of GST rate reduction to the consumers. We have passed the net benefit and communicated the same via advertising in mass media to help increase awareness with the consumers, shoppers and retailers".
The GST rates on about 178 products were cut by the GST Council with effect from 15 November, 2017. The rate rate on washing powder, shampoo, cosmetics and dental hygiene were slashed to 18 percent from the highest slab of 28 percent.
As per GST anti-profiteering rules, companies have to pass on the benefit of reduction of taxes to consumers by way of commensurate cut in product prices. However, there have been complaints from consumers that the firms have increased the base price of products and then charged the lower GST rate, thereby keeping the MRP of products the same in pre and post tax rate cut.
P&G said it will continue to cooperate with the authorities and provide clarifications. "We hope that the authorities concerned will appreciate the procedure followed to pass on the GST benefit and will take a just view of the matter".
Once a profiteering complaint is received against a company, the DGAP has the powers to look into the books of accounts and see if the benefits of tax rate cuts have been passed on in other products manufactured by the company as well.
After studying the documents, the DGAP gives its report to the NAA for further action.
If the NAA finds a firm guilty of profiteering then the amount profiteered has to be refunded to consumers by the company. In case where the consumers cannot be identified, the amount has to be deposited into the consumer welfare fund of the Centre and states.
In December 2018, the NAA had found another FMCG firm HUL guilty of profiteering of Rs 535 crore by not passing on tax rate cut benefits to consumers on its range of products.
Celebrate World Music Day and Pride Month with a carefully curated list of 10 international queer songs
From Queen's 'I Want To Break Free' to Shamir Bailey's 'On My Own,' here are 10 queer songs that have been powerful allies and source of catharsis for the LGBTQ+ community.
Richter Scale 7.6 movie review: Seismic shifts in a father-son equation in the face of displacement and isolation
Empathy and immersion in the milieu are what help Richter Scale 7.6 rise above its rough edges, of which it has a few.
Covishield dose gap row: Harsh Vardhan says decision was taken unanimously; calls controversy 'unfortunate'
Covishield dose gap row: Union health minister Harsh Vardhan too said the decision to increase the gap “has been taken in a transparent manner based on scientific data”